These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30576969)

  • 1. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
    Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
    Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
    Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
    Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
    Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
    Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
    Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
    Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
    Young T; Velikova G; Liegl G; Rose M; Nolte S;
    Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom.
    Pilz MJ; Nolte S; Liegl G; King M; Norman R; McTaggart-Cowan H; Bottomley A; Rose M; Kemmler G; Holzner B; Gamper EM;
    Value Health; 2023 May; 26(5):760-767. PubMed ID: 36572102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EORTC QLQ-C30 general population normative data for the United States.
    Rogge AA; Liegl G; Snyder C; Rose M; Nolte S;
    Eur J Cancer; 2024 May; 202():114030. PubMed ID: 38552543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients.
    Dirven L; Groenvold M; Taphoorn MJB; Conroy T; Tomaszewski KA; Young T; Petersen MA;
    Qual Life Res; 2017 Nov; 26(11):2919-2929. PubMed ID: 28707048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
    de Ligt KM; Aaronson NK; Liegl G; Nolte S;
    Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
    Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
    Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research.
    Giesinger JM; Loth FLC; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; van Leeuwen M; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
    J Clin Epidemiol; 2020 Jan; 117():117-125. PubMed ID: 31593797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of standard computerised adaptive test (CAT) settings for the EORTC CAT Core.
    Petersen MA; Vachon H; Giesinger JM; Groenvold M;
    Qual Life Res; 2024 Apr; 33(4):951-961. PubMed ID: 38231438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT).
    Gamper EM; Petersen MA; Aaronson N; Costantini A; Giesinger JM; Holzner B; Kemmler G; Oberguggenberger A; Singer S; Young T; Groenvold M;
    Health Qual Life Outcomes; 2016 May; 14():72. PubMed ID: 27150974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and psychometric evaluation of item banks for memory and attention - supplements to the EORTC CAT Core instrument.
    Rogge AA; Petersen MA; Aaronson NK; Conroy T; Dirven L; Fischer F; Habets E; Reijneveld JC; Rose M; Sleurs C; Taphoorn M; Tomaszewski KA; Vachon H; Young T; Groenvold M;
    Health Qual Life Outcomes; 2023 Nov; 21(1):124. PubMed ID: 37968682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.